Heart Defects, Congenital  >>  Synagis (palivizumab)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Synagis (palivizumab) / SOBI
NCT01075178: Retrospective Palivizumab Study in Children With Hemodynamically Significant Congenital Heart Disease

Completed
N/A
2036
Europe
Abbott
Severe Respiratory Syncytial Virus Infection
01/10
01/10

Download Options